XPA Gene Xeroderma pigmentosum group A Genetic Test
Cost: AED 4400.0
Test Components:
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test gene XPA.
Test Details:
XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is a genetic test that analyzes the XPA gene for mutations associated with Xeroderma pigmentosum, group A (XP-A). Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) light, leading to severe sunburns, freckling, and an increased risk of skin cancer.
The NGS (Next-Generation Sequencing) technology used in this test allows for the simultaneous analysis of multiple genes, including the XPA gene, to identify any disease-causing mutations. This comprehensive approach increases the accuracy and efficiency of genetic testing, enabling healthcare professionals to make an accurate diagnosis and provide appropriate management and treatment options for individuals with XP-A.
The XPA gene is responsible for producing a protein involved in DNA repair. Mutations in this gene can impair the ability of cells to repair DNA damage caused by UV light exposure. As a result, individuals with XP-A are more susceptible to developing skin cancer at an early age.
The XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is typically recommended for individuals with clinical symptoms suggestive of XP-A or a family history of the condition. It can help confirm the diagnosis, provide information on disease severity, and guide appropriate management strategies, such as strict sun protection measures and regular skin cancer screenings.
It is important to note that this test is typically performed by healthcare professionals who specialize in genetics or genetic counseling. The results of the test should be interpreted in conjunction with the individual’s clinical presentation and family history to provide accurate genetic counseling and appropriate medical management.
| Test Name | XPA Gene Xeroderma pigmentosum group A Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XPA Gene Xeroderma pigmentosum, group A NGS Genetic DNA Test gene XPA |
| Test Details | XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is a genetic test that analyzes the XPA gene for mutations associated with Xeroderma pigmentosum, group A (XP-A). Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet (UV) light, leading to severe sunburns, freckling, and an increased risk of skin cancer. The NGS (Next-Generation Sequencing) technology used in this test allows for the simultaneous analysis of multiple genes, including the XPA gene, to identify any disease-causing mutations. This comprehensive approach increases the accuracy and efficiency of genetic testing, enabling healthcare professionals to make an accurate diagnosis and provide appropriate management and treatment options for individuals with XP-A. The XPA gene is responsible for producing a protein involved in DNA repair. Mutations in this gene can impair the ability of cells to repair DNA damage caused by UV light exposure. As a result, individuals with XP-A are more susceptible to developing skin cancer at an early age. The XPA Gene Xeroderma pigmentosum, group A NGS Genetic Test is typically recommended for individuals with clinical symptoms suggestive of XP-A or a family history of the condition. It can help confirm the diagnosis, provide information on disease severity, and guide appropriate management strategies, such as strict sun protection measures and regular skin cancer screenings. It is important to note that this test is typically performed by healthcare professionals who specialize in genetics or genetic counseling. The results of the test should be interpreted in conjunction with the individual’s clinical presentation and family history to provide accurate genetic counseling and appropriate medical management. |
